➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Mallinckrodt
Dow
Baxter
Johnson and Johnson

Last Updated: September 24, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ENTOCORT EC

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Entocort Ec

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00135408 ↗ A Study of MDX-010 (BMS-734016) Administered With or Without Prophylactic Oral Budesonide Completed Medarex Phase 2 2005-12-01 The purpose of the study is to determine Efficacy, Safety and Tolerability of MDX-010 (BMS-734016) administered with or without Prophylactic Oral Budesonide.
NCT00135408 ↗ A Study of MDX-010 (BMS-734016) Administered With or Without Prophylactic Oral Budesonide Completed Bristol-Myers Squibb Phase 2 2005-12-01 The purpose of the study is to determine Efficacy, Safety and Tolerability of MDX-010 (BMS-734016) administered with or without Prophylactic Oral Budesonide.
NCT00343642 ↗ Dietary Treatment of Crohn's Disease Completed National Center for Complementary and Integrative Health (NCCIH) Phase 1/Phase 2 2006-09-01 Our objective is to determine whether a specific dietary intervention or a fructooligosaccharide (FOS) supplement has anti-oxidant or prebiotic effects and whether it is beneficial in the treatment of Crohn's Disease (CD.
NCT00343642 ↗ Dietary Treatment of Crohn's Disease Completed Rush University Medical Center Phase 1/Phase 2 2006-09-01 Our objective is to determine whether a specific dietary intervention or a fructooligosaccharide (FOS) supplement has anti-oxidant or prebiotic effects and whether it is beneficial in the treatment of Crohn's Disease (CD.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Entocort Ec

Condition Name

Condition Name for Entocort Ec
Intervention Trials
Crohn's Disease 4
Inflammatory Bowel Disease 2
Ulcerative Colitis 2
Stem Cell Transplantation 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Entocort Ec
Intervention Trials
Crohn Disease 4
Ulcer 2
Colitis, Ulcerative 2
Colitis 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Entocort Ec

Trials by Country

Trials by Country for Entocort Ec
Location Trials
United States 26
Canada 5
Poland 5
Italy 4
United Kingdom 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Entocort Ec
Location Trials
New York 4
Illinois 3
Georgia 3
New Jersey 2
Minnesota 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Entocort Ec

Clinical Trial Phase

Clinical Trial Phase for Entocort Ec
Clinical Trial Phase Trials
Phase 4 1
Phase 3 3
Phase 2 3
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Entocort Ec
Clinical Trial Phase Trials
Completed 5
Terminated 3
Not yet recruiting 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Entocort Ec

Sponsor Name

Sponsor Name for Entocort Ec
Sponsor Trials
Perrigo Company 2
Pooja Budhiraja, MD 1
Valeant Pharmaceuticals International, Inc. 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Entocort Ec
Sponsor Trials
Industry 7
Other 5
NIH 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Dow
AstraZeneca
Johnson and Johnson
Medtronic
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.